Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Payables (2019 - 2025)

Bioadaptives' Payables history spans 7 years, with the latest figure at $262864.0 for Q3 2025.

  • For Q3 2025, Payables fell 48.01% year-over-year to $262864.0; the TTM value through Sep 2025 reached $262864.0, down 48.01%, while the annual FY2024 figure was $211554.0, 52.31% down from the prior year.
  • Payables for Q3 2025 was $262864.0 at Bioadaptives, down from $515081.0 in the prior quarter.
  • Across five years, Payables topped out at $831413.0 in Q2 2022 and bottomed at $110973.0 in Q1 2021.
  • The 5-year median for Payables is $562867.0 (2021), against an average of $555228.8.
  • The largest annual shift saw Payables soared 560.37% in 2022 before it crashed 52.31% in 2024.
  • A 5-year view of Payables shows it stood at $650867.0 in 2021, then rose by 21.64% to $791713.0 in 2022, then crashed by 43.97% to $443579.0 in 2023, then plummeted by 52.31% to $211554.0 in 2024, then rose by 24.25% to $262864.0 in 2025.
  • Per Business Quant, the three most recent readings for BDPT's Payables are $262864.0 (Q3 2025), $515081.0 (Q2 2025), and $507816.0 (Q1 2025).